Year: 2021

Wilhelmina International, Inc. Reports Results for Third Quarter 2021

Written by Customer Service on November 15, 2021. Posted in Earnings Releases And Operating Results.

Third Quarter Financial Results (in thousands) Q3 21 Q3 20 YOYChange Q3 21 YTD Q3 20 YTD YOYChangeTotal Revenues $ 15,109 $ 10,545 43.3 % $ 41,595 $ 29,625 40.4 %Operating Income (Loss) 1,018 114 * 2,009 (4,665 ) 143.1 %Income (Loss) Before Provision for Taxes 1,473 107 * 5,190 (4,671 ) 211.1 %Net Income (Loss) 1,153 22 * 4,495 (5,338 ) 184.2 %EBITDA** 1,711 422 305.5 % 5,979 (3,714 ) 261.0 %Adjusted EBITDA** 1,251 411 204.4 % 2,755 (2,966 ) 192.9 %Pre-Corporate EBITDA** 1,451 556 161.0 % 3,398 (2,274 ) 249.4 %* Not Meaningful **Non-GAAP measures referenced are detailed in the disclosures at the end of this release.DALLAS, Nov. 15, 2021 (GLOBE NEWSWIRE) — Wilhelmina International, Inc. (Nasdaq:WHLM) (“Wilhelmina” or the...

Summit Therapeutics Inc Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2021

Written by Customer Service on November 15, 2021. Posted in Earnings Releases And Operating Results.

Cambridge, Massachusetts, Nov. 15, 2021 (GLOBE NEWSWIRE) — Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today reports its financial results and provides an update on its operational progress for the third quarter and nine months ended September 30, 2021. Note: A glossary of terms is included at the end of this document in order to allow for the ease of understanding of terms or concepts used throughout this release. Financial HighlightsAggregate cash, accounts receivable, and tax credits receivable on September 30, 2021 totaled $103.9 million as compared to $76.6 million on December 31, 2020. Our cash balance on September 30, 2021 was $80.2 million as compared to $66.4 million on December 31, 2020. Accounts receivable and research and development tax credits receivable...

Harbor Custom Development, Inc. Reports 2021 Third Quarter Results

Written by Customer Service on November 15, 2021. Posted in Earnings Releases And Operating Results.

GIG HARBOR, Wash., Nov. 15, 2021 (GLOBE NEWSWIRE) — Harbor Custom Development, Inc. (“Harbor,” “Harbor Custom Homes®,” or the “Company”), (NASDAQ: HCDI; HCDIP; HCDIW, HCDIZ), an innovative and market leading real estate company involved in all aspects of the land development cycle, today announced the financial results for the third quarter ended September 30, 2021. Third Quarter 2021 Financial Highlights Compared to Third Quarter 2020Consolidated net sales of $18.0 million, compared to $7.8 million Gross profit of $7.1 million, compared to $0.6 million Selling General & Administrative (“SG&A”) of $3.3 million, compared to $1.5 million Net income of $3.7 million, or $0.21 basic earnings per share (EPS), compared to a net loss of ($0.4) million, or ($0.10) EPSNine Months 2021 Financial Highlights Compared to Nine Months...

Bellerophon Provides Clinical Program Update and Reports Third Quarter 2021 Financial Results

Written by Customer Service on November 15, 2021. Posted in Earnings Releases And Operating Results.

WARREN, N.J., Nov. 15, 2021 (GLOBE NEWSWIRE) — Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the third quarter ended September 30, 2021. “We remain focused on advancing the development of our INOpulse® inhaled nitric oxide therapy in fibrotic interstitial lung disease, or fILD, and sarcoidosis, or PH-Sarc, which are two areas of severe unmet medical need,” said Naseem Amin, M.D., Chairman of Bellerophon’s Board of Directors. “Our pivotal Phase 3 REBUILD study in fILD is continuing to enroll. Importantly, INOpulse is the first potential therapy to treat a broad fILD population that includes patients at low, intermediate,...

Delta 9 Reports Financials for Q3 2021

Written by Customer Service on November 15, 2021. Posted in Earnings Releases And Operating Results.

WINNIPEG, Manitoba, Nov. 15, 2021 (GLOBE NEWSWIRE) — DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) (“Delta 9” or the “Company”), is pleased to announce financial and operating results for the three-month and nine-month period ending September 30, 2021. Financial Highlights for the three-month period ending September 30, 2021Net revenue of $15.2 million for the third quarter of 2021, an increase of 16%, from $13.1 million for the same quarter last year. Gross profit of $4.8 million for the third quarter of 2021, an increase of 55%, from $3.1 million for the same quarter last year. Net loss from operations of $(55,031) for the third quarter of 2021 versus a loss from operations of $(4,578,729) for the same quarter last year. Adjusted EBITDA of $191,056 for the third quarter of 2021 versus an adjusted EBITDA of $210,756 million...

Sugarbud Announces Record Quarterly Revenue, Filing of Q3 2021 Financial Results and Corporate Update

Written by Customer Service on November 15, 2021. Posted in Earnings Releases And Operating Results.

Calgary, ALBERTA, Nov. 15, 2021 (GLOBE NEWSWIRE) — Sugarbud Craft Growers Corp. (TSXV: SUGR, SUGR.DB, SUGR.WR, SUGR.WS, SUGR.WT) (OTCQB: SBUDF) (“Sugarbud”) is pleased to announce the filing of its unaudited condensed consolidated interim financial statements (“Financial Statements”) for the three and nine months ended September 30th, 2021 and related management’s discussion and analysis (“MD&A”). Sugarbud’s Financial Statements and MD&A are available on SEDAR at www.sedar.com and on Sugarbud’s website here: Sugarbud Q3, 2021 Financials and MD&A. The Company is also pleased to announce the appointment of Mr. John Reilly as Special Advisor to the Board of Directors. Key Operating Highlights for Q3 2021Record Total Grams Shipped | The Company shipped a record...

ESE Completes Acquisition of European Esports Media Company, Frenzy

Written by Customer Service on November 15, 2021. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, Nov. 15, 2021 (GLOBE NEWSWIRE) — ESE Entertainment Inc. (“we”, “ESE”, or the “Company”) (TSXV: ESE) (OTCQB: ENTEF) is pleased to announce that is has completed its previously announced acquisition of 100% of the shares of Frenzy sp. z.o.o. (“Frenzy”), a European esports media and technology company. Frenzy is a media and production infrastructure company focused on the video game industry, which creates and executes esports and gaming events, broadcasts, and media content. For more information about Frenzy, please see the Company’s press releases dated September 30, 2021 and October 25, 2021. Under the terms of the share purchase agreement dated October 21, 2021, ESE acquired 100% of the issued and outstanding shares of Frenzy (the “Transaction”). The purchase price consisted of (i) CAD $1,183,122.94...

Patriot National Bancorp and American Challenger Development Corp. agree to merge and create largest digital challenger bank in America

Written by Customer Service on November 15, 2021. Posted in Mergers And Acquisitions.

Combination will create a purpose-driven, digital-first national bank offering better rates and a premium customer experience Patriot enters into separate agreements with investors to provide $540 million as part of its $890 million merger recapitalization STAMFORD, Conn., Nov. 15, 2021 (GLOBE NEWSWIRE) — Patriot National Bancorp, Inc. (“Patriot” (NASDAQ: PNBK)), the parent company of Patriot Bank, N.A. (the “Bank”), and American Challenger Development Corp. ( “American Challenger”), announced today that they have entered into a definitive agreement (the “Merger Agreement”) under which Patriot will acquire American Challenger via a reverse subsidiary merger, with American Challenger surviving as a wholly owned subsidiary of Patriot (the “Merger”). Pursuant to the terms of the Merger Agreement, at the effective time...

Accelus, an Emerging Leader in Minimally Invasive Spine Surgery, and CHP Merger Corp. Announce Proposed Business Combination

Written by Customer Service on November 15, 2021. Posted in Mergers And Acquisitions.

Transaction expected to combine Accelus and CHP Merger Corp., a leading healthcare-focused SPAC. The pro-forma enterprise value of the business combination would be approximately $482 million. Chris Walsh, Accelus CEO and Co-Founder, will become CEO of the combined company, Accelus. Mr. Walsh has 25 years of experience at leading spinal health companies, including Stryker and NuVasive. Joseph Swedish, Chairman of CHP Merger Corp., and seasoned industry executive Alex Lukianov will join the Board of Directors of the combined company. Mr. Swedish has decades of healthcare industry experience having served in positions at Anthem, Trinity Health, Centura and HCA Healthcare. Mr. Lukianov has over 35 years of leadership and entrepreneurial experience across several leading medical technology companies, including NuVasive, BackCare Group, Smith...

Ayala Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update

Written by Customer Service on November 15, 2021. Posted in Earnings Releases And Operating Results.

– Presented Preliminary Clinical Data from 6mg Cohort of Phase 2 ACCURACY Trial of AL101 in R/M ACC Demonstrating 70% Disease Control Rate at ESMO 2021 – – Presented Pre-Clinical Proof of Concept Data for Enhanced Activity of AL101 in Combination with Approved Cancer Therapies in ACC- – Published Case Studies Highlighting Clinical Activity of AL101 with Long-Lasting Responses in Patients with Desmoid Tumors – – Enrollment in All Ongoing Studies is on Track and Have Progressed as Planned – – Multiple Milestones Across Clinical-Stage Pipeline Expected in 2022 – REHOVOT, Israel & WILMINGTON, Del., Nov. 15, 2021 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (Nasdaq: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering...

Year: 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals